Hjem › Blærecancer › Montana › Kalispell
Blærecancer kliniske forsøg i Kalispell, MT
4 studier for Blærecancer søger deltagere på steder i og omkring Kalispell (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RekruttererFase 3
- Logan Health Medical Center, Kalispell
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Logan Health Medical Center, Kalispell
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- Logan Health Medical Center, Kalispell
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RekruttererFase 3
- Logan Health Medical Center, Kalispell
Blærecancer forsøg i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Boston, MA26 studier
- Washington, DC26 studier
- Los Angeles, CA24 studier
- Baltimore, MD24 studier
- St. Louis, MO22 studier
- Philadelphia, PA21 studier
- Seattle, WA21 studier
- Edison, NJ21 studier
Andre studier i Kalispell
- Ikke-småcellet lungecancer9 studier
- Lungecancer8 studier
- Prostatakræft8 studier
- Akut myeloid leukæmi6 studier
- Pladecellekræft i hoved og hals5 studier
- Melanom5 studier
- Colorektal kræft4 studier
- Tyktarmskræft4 studier
- Livmoderslimhindekræft3 studier
- Nyrekancer (renocellulært karcinom)3 studier
- Hypofarynxcancer3 studier
- Larynxcancer3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.